Vaccine Access in Africa – Data Sources
1. ONE Campaign / Africa CDC
98.9% of Africa’s vaccines are imported. Africa produces just 0.2% of the world’s vaccines.
Source: ONE Campaign & Africa CDC (2024)
2. WHO (2024)
Vaccines have saved at least 154 million lives in the past 50 years.
Source: World Health Organization (2024)
3. Gavi – Vaccine Manufacturing
Only 8 out of 54 African countries have local vaccine production.
Source: Gavi, the Vaccine Alliance (2024)
4. UNICEF
127 million children missed one or more vaccines in Africa between 2019 and 2021.
Source: UNICEF (2023)
5. Gavi – Needle-Free Vaccine Innovation (MAPs)
11 needle-free vaccines could transform global immunization.
Source: Gavi, the Vaccine Alliance (2023)
6. Gavi / NEC / Simprints – Biometric Fingerprinting for Vaccination
Deploying the world’s first scalable child fingerprint ID for immunization.
Source: Gavi, NEC & Simprints (2023)
7. Nigeria’s National Vaccine Policy (2021) – Nigerian Economic Summit Group (NESG)
Promotes equity, innovation, and local vaccine ownership. This policy aligns with LunaVax’s mission to support local production, equitable access, and innovative delivery across Nigeria.
Source: National Vaccine Policy, Federal Republic of Nigeria (2021), published by NESG. Download the policy PDF
8. African Development Bank (AfDB, 2023)
Africa’s youth population (ages 15–24) is expected to grow from 230 million in 2015 to 850 million by 2050, making Africa home to the world’s largest and youngest working-age population.
Source: AfDB Youth Presentation PDF (2023)
9. UN DESA – World Population Prospects (2015 Revision)
Africa’s population is projected to nearly double by 2050, reaching approximately 2.5 billion. Within that, the youth population (ages 15–24) is expected to grow from 230 million in 2015 to 850 million, making Africa home to the world’s largest and youngest working-age population.
Source: UN DESA – World Population Prospects: 2015 Revision
10. African Vaccine Manufacturing Initiative (AVMI) – Vaccine Market and Procurement Analysis (VMPA) Study (2017)
This study explores how global procurement and funding mechanisms—while aiming for equity—can unintentionally exclude locally manufactured vaccines, especially in African contexts.
Source: VMPA Study PDF
11. MedAccess (2025)
Africa buys over a quarter of the world’s vaccines—but produces less than 1%. Regulatory obstacles and procurement policies favoring established global suppliers continue to limit local manufacturing.
Source: medaccess.org (Accessed July 2025)
12. Gavi (2025)
In April 2025, Gavi and Zipline used drones to deliver malaria vaccines to over 20,000 children in remote communities across Bayelsa State, Nigeria—demonstrating how aerial delivery can bridge access gaps in hard-to-reach areas.
Source: gavi.org – Flying malaria vaccines reach isolated Nigerian communities (Accessed July 2025)